Prof Carine Smith, head of the multidisciplinary stress biology research group at the Department of Physiological Sciences at SU, says recent research has shown that the HI-virus initiates chronic inflammation of the central nervous system soon after an individual becomes infected.
“This neuro-inflammation promotes the development of neurodegeneration and dementia, a process which is thus already in progress before the roll-out of anti-retroviral (ARV) therapy.
"The ideal therefore would be to use something to limit the extent of neuro-inflammation, especially as ARV drugs have not been designed for this purpose."
But while earlier research supports the benefits of Sutherlandia for alleviating stress in healthy individuals, the picture changes when an individual is infected with the HI-virus.
Prof Smith explains: “Our data, obtained in a validated cell co-culture simulation of the human blood-brain barrier, support earlier work of the beneficial action of Sutherlandia but only in non-HIV conditions.
"In the HIV+ condition, HIV-associated proteins caused more severe neuro-inflammation as more immune cells moved across the blood brain barrier after being treated with Sutherlandia.”
The results of this research have recently been published in an article “Sutherlandia frutescens may exacerbate HIV-associated neuroinflammation” in the Journal of Negative Results in BioMedicine.
Prof. Smith says their research by no means argues against the use of Sutherlandia as originally prescribed by indigenous knowledge practitioners: “Our research on plant medicines is aimed at distinguishing between populations and conditions that would most benefit from a specific plant and those who would do better to avoid talking it at all.”
“We therefore caution against the use of Sutherlandia frutescens at any stage post HIV-infection,” she concludes.
Her research group is, however, finding promising results on the effect of grape seed extracts on inflammation, especially after muscle injury, as well as neuro-inflammation. Clinical trials on the effect of grape seed extract on healthy individuals will start early in 2016.